INCY 241220 67.50P (INCY241220P67500) Stock Options, News & Quotes

US OptionsDetailed Quotes

INCY241220P67500

Watchlist

1.30
-0.35-21.21%

15min DelayClose Nov 25 15:59 ET

2.02High1.00Low

Intraday

5D
Daily

News

Express News | Incyte To Present Late-Breaking Tafasitamab Data In Follicular Lymphoma At ASH 2024 Alongside 20 Oncology Portfolio Updates, Including Phase 3 InMIND Results And Virtual Analyst Event On December 12
BenzingaNov 25 10:10 ET
S&P 500, Dow Hit Records Right After Open | Live Stock
Kevin TraversNov 25 10:00 ET
TD Cowen Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $86
Moomoo NewsNov 25 08:32 ET · Ratings
TD Cowen Remains a Buy on Incyte (INCY)
TipRanksNov 25 07:47 ET · Ratings
TD Cowen Adjusts Price Target on Incyte to $86 From $80, Keeps Buy Rating
MT NewswiresNov 25 06:47 ET · Ratings
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Kevin TraversNov 22 16:17 ET

Comments

韭菜变主力

Nov 19 12:59

$Merck & Co (MRK.US)$ $Incyte (INCY.US)$ is a great company. Buying it would be a good decision, unless Merck massively overpays.

The Thinker

Oct 29 19:14

Tech Stocks Surge While Dow Falters as U.S. Markets Prepare for Key Data

Click Here: TYNKR LAB™
U.S. stock markets closed with mixed results, reflecting cautious investor sentiment as major tech earnings approached alongside key economic data. $Dow Jones Industrial Average (.DJI.US)$ fell by 0.36%, while $S&P 500 Index (.SPX.US)$ and $Nasdaq Composite Index (.IXIC.US)$ posted gains of 0.16% and 0.81%, respectively. This divergence highlights sector-specific movements and investor positioning ahead ...

🚨 This Week’s PDUFAs:
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...

Trytosaveabit

Aug 14 16:41

News

$Syndax Pharmaceuticals (SNDX.US)$ $Incyte (INCY.US)$ Reuters
5 mins ago
Incyte and Syndax Announce U.S. FDA Approval of Niktimvo™ (Axatilimab-Csfr) for the Treatment of Chronic Graft-Versus-Host Disease (Gvhd)